DLD Asset Management’s Acceleron Pharma XLRN Stock Holding History

DLD Asset Management’s Portfolio XLRN Stock Details XLRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-10,000	Closed	-$1.72M	–	208
2021 Q3	$1.72M	Buy	+10,000	New	+$1.31M	0.13%	75
2018 Q4	–	Sell	-498,300	Closed	-$28.5M	–	109
2018 Q3	$28.5M	Buy	+498,300	New	+$24.5M	1.41%	16

DLD Asset Management's XLRN Position: Q3 2018 in Review

DLD Asset Management sold out of Acceleron Pharma (XLRN) in Q3 2018, closing a stake of 130,606 shares — an estimated $6.42M sold.

DLD Asset Management first reported a position in XLRN in Q2 2018 and held it in 1 quarter. The position peaked at $6.34M in Q2 2018. 167 funds tracked by Wall St. Rank hold XLRN as of Q3 2018.

DLD Asset Management reported no remaining Acceleron Pharma position as of Q3 2018 after selling out during the quarter.
DLD Asset Management sold 130,606 Acceleron Pharma shares in Q3 2018, an estimated $6.42M.
DLD Asset Management first reported a position in Acceleron Pharma in Q2 2018 and held it in 1 quarter.
DLD Asset Management's Acceleron Pharma position peaked at $6.34M in Q2 2018.
167 funds tracked by Wall St. Rank held Acceleron Pharma as of Q3 2018.

Based on DLD Asset Management's 13F filing for Q3 2018, filed 13 Nov 2018.